Jain describes the phase 3 WIL-33 trial, which marked the first test of pdVWF/FVIII in adolescent patients aged <6 years.
Akshat Jain, MD, MPH
Advertisement
Jain is the medical director of the pediatric and young adult program for hemostasis/thrombosis and sickle cell disease at Loma Linda University Children’s Health.
Articles by Akshat Jain, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
How Dermatology PAs Can Master Rapid Diagnostic Recognition
2
STAT6, ITK Inhibitors, IL-31, & IL-18 Headline Burgeoning Pipeline in Atopic Dermatitis, with David Rosmarin, MD
3
Emerging Evidence in Atopic Dermatitis Management, With Harrison Nguyen, MD, MBA, MPH
4
Managing FCS: LPL-Targeted Therapy, Drug Rationalization, and Atherosclerosis Risk
5